Background:
Acute liver injury (ALI) is a critical and fatal disorder which is associated with excessive oxida¬tive stress and inflammation and ultimate death of hepatocytes. Myricetin is a bioflavonoid in some berries including blueberries and strawberries with anti-inflammatory, antioxidant and anti-apoptotic properties.
Objective:
In the current research, hepatoprotective potential of myricetin was studied in LPS/D-GalN model of ALI in C57BL/6 mice.
Methods:
For inducing liver injury, D-GalN (400 mg/kg) and LPS (50 g/kg) was injected via intraperitoneal route and myricetin was orally administered (25 or 100 mg/kg/day), from two days till 1 h before inducing injury. Functional indices of liver dysfunction along with hepatic apoptotic, autophagic, oxidative stress and inflammatory factors were measured.
Results:
Myricetin (100 mg/kg) reduced lethality rate of animals and liver pathological changes and suitably lowered serum levels of total bilirubin, 8-OH-dG, ALT, AST and ALP in addition to decreasing apoptotic, oxidative and inflammatory factors, NOX, NLRP3, caspase 3, MPO and enhancing some antioxidants. Besides, myricetin improved hepatic level and activity of sirtuin 1 and reversed inappropriate alterations of autophagic parameters including LC3 II, Beclin 1 and P62. Beneficial effects of myricetin was attenuated after co-treatment with the autophagy inhibitor 3-methyladenine.
Conclusion:
This study indicates hepatoprotective potential of myricetin that can be ascribed to its down-regulation of oxidative, apoptotic and inflammatory factors and upregulation of antioxidants besides its partial regulation of sirtuin 1 and autophagic pathway.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.